Drug Profile
ZCL 8
Latest Information Update: 19 Mar 2009
Price :
$50
*
At a glance
- Originator A.S.A.C. Pharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 19 Mar 2009 Discontinued - Phase-I for Psoriasis in Germany (Topical)
- 08 May 2003 Phase-I clinical trials in Psoriasis in Germany (Topical)
- 20 Mar 2001 Phase-I clinical trials for Psoriasis (Topical)